Windlas Biotech (NSE:WINDLAS) 3-Year Revenue Growth Rate : 32.20% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech 3-Year Revenue Growth Rate?

Windlas Biotech's Revenue per Share for the three months ended in Mar. 2024 was ₹81.43.

During the past 12 months, Windlas Biotech's average Revenue per Share Growth Rate was 27.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 32.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Windlas Biotech was 32.20% per year. The lowest was 16.30% per year. And the median was 17.30% per year.

Competitive Comparison of Windlas Biotech's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Windlas Biotech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Windlas Biotech's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Windlas Biotech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Windlas Biotech's 3-Year Revenue Growth Rate falls into.

Windlas Biotech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Windlas Biotech (NSE:WINDLAS) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Windlas Biotech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Windlas Biotech (NSE:WINDLAS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (NSE:WINDLAS) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

543329:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulations contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech (NSE:WINDLAS) Headlines

No Headlines